A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
for Type 1 Diabetes Mellitus
32 locations incl. Scottsdale
Sponsor: Sanofi
Sex: All·Age: 1 - 25
Code: NCT07088068·Phase 3·Recruiting